Turning Cancer Data Chaos into Actionable Insights
Data Silos in Cancer Care undermine advances in research and treatment. Nearly 90% of healthcare data exists in unstructured formats. In oncology, crucial patient data is scattered across hospitals, labs, EHRs, and even wearables-making it tough for researchers and clinicians to get the full picture. This fragmentation leads to: Delayed diagnoses & treatment decisions Missed […]
Uterine Cancer Awareness Month
June is Uterine Cancer Awareness Month. These cancers include endometrial cancers and uterine sarcomas. Did you know that endometrial cancer is the most common gynecologic cancer in the U.S., projected to affect over 69,000 women and cause nearly 14,000 deaths in 2025, according to the American Cancer Society In March 2025, researchers at the Icahn […]
ASCO 2025 Takeaways
ASCO 2025: Where Oncology’s Brightest Minds Meet—and Clinakos Inc. Listens Closely We’re back from the American Society of Clinical Oncology (ASCO) Annual Meeting, energized and inspired by the innovations shaping the future of cancer care. It was especially good seeing our partner Wes Michael of Rare Patient Voice—collaborations like these are vital as we work […]
National Cancer Survivors Day
Yesterday, the world celebrated National Cancer Survivors Day—but at Clinakos Inc., we believe every day is a chance to honor survivors’ strength, stories, and hope. Survivors aren’t just statistics—they’re the reason we innovate. Take Kris Carr, for example. Diagnosed in 2003 with a rare and incurable Stage IV cancer called epithelioid hemangioendothelioma, Kris transformed her […]
Rare Diseases: No Longer in the Shadows
Rare Diseases: No Longer in the Shadows! This week, the world hit a milestone at the Global Health Summit in Geneva: rare diseases where nearly 200 countries adopted a resolution to prioritize rare disease care At Clinakos Inc., we see this as more than just a headline—it’s a call to action. For the 300 million […]
Exciting news for the rare cancer research community!
Exciting news for the rare cancer research community! The U.S. Department of Defense’s Rare Cancers Research Program (RCRP) is rolling out significant new funding opportunities in 2025 to accelerate research and innovation in rare cancers. Backed by the Congressionally Directed Medical Research Programs (CDMRP), the FY25 RCRP will support projects with exceptional scientific merit— fueling […]
Our Partner, Axtria’s ISPOR 2025 Decoded
We’re still feeling the ISPOR 2025 excitement—and our friends at Axtria – Ingenious Insights captured it perfectly in their latest recap! Their article, “ISPOR 2025 Decoded: Axtria’s Must-See Insights and Emerging Themes”, shines a spotlight on the big ideas, bold innovations, and, yes, the brilliant partnerships shaping the future of healthcare. We’re thrilled to see […]
We’re Exhibiting at 2025 ASCO Annual Meeting
The countdown is on—just 3 days until ASCO25! Clinakos is excited to be part of this year’s pivotal gathering focused on “Driving Knowledge to Action: Building a Better Future.” This theme is woven throughout the ASCO 2025 agenda, emphasizing turning scientific discoveries and data into real-world patient solutions. With sessions dedicated to AI in oncology, […]
Cystic Fibrosis Awareness Month
This May, for Cystic Fibrosis Awareness Month, we’re honored to share Nikki’s story- a powerful testament to resilience and hope. Diagnosed with cystic fibrosis at age 5, Nikki faced a lifetime of challenges: daily treatments, declining lung function, and the uncertainty of waiting years for a double lung transplant. Despite the odds, Nikki’s determination never […]
What Surprised, Inspired, and Challenged Us at ISPOR 2025
✨What Surprised, Inspired, and Challenged Us at ISPOR 2025: Clinakos Inc.’s Field Notes✨ After four whirlwind days at ISPOR 2025 in Montreal, our Clinakos team returned with notebooks full of ideas, a few new friends, and a renewed sense of where HEOR is heading. Instead of a classic list, here’s a look at the moments […]
